Trial Profile
Therapy of Early Stage Myelodysplastic Syndrome (MDS) With ATG [antithymocyte globulin] and Etanercept
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Apr 2022
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary) ; Etanercept
- Indications Leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 26 May 2009 Inclusion and exclusion criteria amended from NCT.
- 26 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Oct 2008 Planned end date changed from 1 Dec 2007 to 1 Aug 2009 as reported by ClinicalTrials.gov.